#
Aug 4, 2024
MOVE FSHD study update.
#
Jul 11, 2024
Patient study update by Dr. Kyba after a Covid hiatus.
#
Jun 27, 2024
Findings indicate selective interactions of RNA binding proteins with HSATII RNA, which may impact mRNA processing pathways downstream of DUX4 expression; and that HSATII RNA structure dictates protein recruitment.
#
Jun 20, 2024
FSHD Straight Talk: 2024 World FSHD Special!
#
May 30, 2024
First year progress.
#
May 18, 2024
The progress report highlights advancements in constructing an MRI data-lake for studying Facioscapulohumeral Muscular Dystrophy (FSHD) using AI segmentation techniques.
#
May 18, 2024
Finalizing biopsy fiducial details to ensure correspondence between histology, DUX4, and MRI data, with atlas generation to begin in earnest in the summer of 2024.
#
May 16, 2024
Developing a comprehensive understanding of DUX4 gene regulation.
#
Apr 23, 2024
Understanding how FSHD cells differ in autophagy and mitophagy will allow one to identify the key mechanisms involved in this metabolic dysregulation of the disease and identify potential therapeutics. Dr. Heher provides a 6-month update on his work so far.
#
Mar 17, 2024
Dr. Bugiardini provides the first update to comprehensively understanding global genetic diversity in FSHD.
#
Feb 17, 2024
An update on the MOVE FSHD study.
#
Feb 17, 2024
Dr. Heher's final report on very interesting data regarding oxidative stress.
#
Feb 1, 2024
Dr. Chamberlain is honored by the MDA with the 2024 Legacy Award for Achievement in Research.
#
Jan 30, 2024
Dr. Arends provides an update to current work.
#
Oct 10, 2023
Latest update from the MOVE grant.
#
Sep 19, 2023
We have developed a computational cellular model of FSHD, based on a mechanism where expression of DUX4 (currently the main target for FSHD therapy) leads to muscle cell death.
#
Jul 5, 2023
Initial progress update.
#
Jul 5, 2023
Friends of FSH Research continues support of local artists, who in turn have donated much to the annual Auction. Live music returns to the Wedgwood Art Festival this year! Two headlining bands and a great lineup of local musicians in the Hellbent Brewery beer garden.
#
Apr 6, 2023
Final update by Dr. Ozes of Altay Therapeutics.
#
Mar 23, 2023
FlexFund grant on support for continued development of low-cost FSHD diagnostic test.